577-11-7 Docusate sodium Docusate sodium
Oral Medical Drug Docusate Sodium For Treating Constipation CAS 577-11-7
Quick detail
CAS No.:577-11-7
Other Names:Docusate Sodium
MF:C20H37O7S.Na
EINECS No.:209-406-4
Place of Origin:China (Mainland)
Type:Syntheses Material Intermediates, Other
Purity:60%
Model Number:60%
Appearance:COA, White,wax-like,plastic solid
Introduction
Docusate sodium belongs to the family of medications known as stool softeners. It is used to treat and prevent occasional constipation due to hard stools. Docusate sodium works by increasing the amount of water in the stool, making stools softer and easier to pass. It usually starts to work within 1 to 3 days, but it may take up to 5 days to work.
Docusate sodium Packaging & Shipping
Shipping : within 5-7 days after receive your payment
Packaging : According to customer requirement
Uses
This medication is used to treat occasional constipation. Some medications and conditions can make constipation more likely. Stool softeners such as docusate are often the first method used for preventing and treating this type of constipation. Docusate is often used when straining to have a bowel movement should be avoided (e.g., after a heart attack or surgery).
Docusate is a stool softener. It works by increasing the amount of water the stool absorbs in the gut, making the stool softer and easier to pass.
How should I use this medication
For adults and children older than 12 years, the recommended dose ranges from 100 mg to 200 mg daily.
For children 6 to 12 years old, the recommended dose is 40 mg to 120 mg daily.
For children 3 to 6 years old, the recommended dose is 20 mg to 60 mg daily.
For children under 3 years of age, your doctor will recommend the appropriate dose.
Interactions
Docusate does not enter into the major interactions with other drugs. So far, only nine moderate and one minor interactions were recorded. Docusate sodium should not be used together with the following substances:
Droperidol (an antipsychotic). Using these two drugs concurrently increases the risk of an increased loss of potassium and magnesium from the body.
Licorice supplements. Using Docusate and licorice together increases the risk of an increased loss of potassium and magnesium from the body.
Mineral oil. Using mineral oil concurrently with Docusate, increases the risk of inflammation of bowels, liver and spleen.
Other laxatives (e.g. phenolphthalein and lactulose)
Safety Info
Symbol: | GHS05 |
Sign: | Danger |
hazard declaration: | H315; H318 |
hazard declaration add: | |
waring notice: | P280; P305 + P351 + P338 |
RTECS: | WN0525000 |
Safety Statements: | S26-S37/39 |
HS Code: | 2914509090 |
WGK Germany: | 2 |
Risk Statements: | R22; R36/37/38 |
Hazard Codes: | Xn |
CAS NO:83-56-7
CAS NO:582-17-2
CAS NO:532-02-5
CAS NO:83-56-7
CAS NO:81-04-9
CAS NO:106-91-2
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View